25-Gauge pars plicata vitrectomy for stage 4 and 5 retinopathy of prematurity

Christine R Gonzales1, Julie Boshra, Steven D Schwartz

  • 1The Jules Stein Eye Institute, Department of Ophthalmology, University of California at Los Angeles, David Geffen School of Medicine, California 90095, USA. Gonzales@jsei.ucla.edu

Retina (Philadelphia, Pa.)
|September 2, 2006
PubMed

Insights

This study shows that 25-gauge vitrectomy is a safe and effective method for treating severe retinopathy of prematurity (ROP) with retinal detachment. The technique achieved retinal reattachment in most cases with manageable complications.

Area of Science:

  • Ophthalmology
  • Pediatric Surgery
  • Retinal Diseases

Background:

  • Retinopathy of prematurity (ROP) can lead to severe tractional retinal detachment.
  • Advanced stages (4 and 5) require surgical intervention.

Purpose of the Study:

  • To detail the technique and report initial outcomes of 25-gauge vitrectomy for stage 4 and 5 ROP.
  • To evaluate the safety and efficacy of this minimally invasive approach.

Main Methods:

  • Retrospective study of 15 eyes with stage 4 or 5 ROP treated with 25-gauge vitrectomy.
  • Modified three-port technique involving conjunctival dissection and sclerotomy suturing.
  • Primary outcome: anatomic success (retinal reattachment).

Main Results:

  • Anatomic success (retinal reattachment) was achieved in 73% of eyes after one or more surgeries.
  • 40% of eyes required lensectomy, and 47% needed repeat surgery.
  • Complications included vitreous hemorrhage and postoperative cataract.

Conclusions:

  • 25-gauge vitrectomy is a safe and effective treatment for advanced ROP with tractional retinal detachment.
  • Outcomes and complications appear comparable to traditional 20-gauge vitrectomy.
  • Surgical modifications included conjunctival and sclerotomy management.
Abstract